FindTrial
Sign In

Vitamin D levels in Rheumatoid Arthritis and their co-relation with disease severity

A study of Vitamin D levels in cases of Rheumatoid Arthritis and their co-relation with disease severity: a cross sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017771
Enrollment
81
Registered
2019-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

KMC Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients above 18 years of age of both sexes who give informed consent. 2. Proven cases of Rheumatoid arthritis as aided by the 2010 EULAR criteria.

Exclusion criteria

Exclusion criteria: 1. Subjects receiving: Vitamin D, calcium, calcitonin, bisphosphonate, oestrogen supplementation, anti-epileptic drugs, thyroxine, steroids in the last 6 months. 2. Subjects having known pathologies interfering with calcium metabolism such as hyperparathyroidism or hypoparathyroidism. 3. Renal failure patients. 4. Patients with known granulomatous diseases like sarcoidosis.

Design outcomes

Primary

MeasureTime frame
Vitamin D levels in a very large number of cases of Rheumatoid Arthritis is expected to be deficient.Timepoint: End of trial period—

Secondary

MeasureTime frame
As severity of RA increases, the vitamin D levels should show an inverse decrease.Timepoint: End of study period (September 2020)—

Countries

India

Contacts

Public ContactDr Wagle Varun Anand

KMC Manipal

varunwagle@yahoo.com9833472084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026